PIXIUM VISION: Expected impairment of IRIS. 2018YE cash position of EUR15.6m | CORPORATE | EUR5,5(
PIXIUM VISION - CORPORATE | EUR5,5(+235%)Expected impairment of IRIS. 2018YE cash position of EUR15.6m
Strong non-R&D costs management
Expected impairment of IRIS following the successes of PRIMA
EUR15.6m cash position offers visibility on 2019 activities
Reiterate FV or EUR5.5/share
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.